|Sensitivity, specificity, and predictors of positive 68Ga–prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and …|
M Perera, N Papa, D Christidis, D Wetherell, MS Hofman, DG Murphy, ...
European urology 70 (6), 926-937, 2016
|Laser ablation of the prostate in patients with benign prostatic hypertrophy|
AJ Costello, WG Bowsher, DM Bolton, KG Braslis, J Burt
British journal of urology 69 (6), 603-608, 1992
|Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma|
S RAMDAVE, GW THOMAS, SU Berlangieri, DM Bolton, IAN DAVIS, ...
The Journal of urology 166 (3), 825-830, 2001
|Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated diagnostic utility, sensitivity, specificity, and distribution …|
M Perera, N Papa, M Roberts, M Williams, C Udovicich, I Vela, ...
European urology 77 (4), 403-417, 2020
|Nd: YAG laser ablation of the prostate as a treatment for benign prostatic hypertrophy|
AJ Costello, DE Johnson, DM Bolton
Lasers in surgery and medicine 12 (2), 121-124, 1992
|Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy|
EJ Hamilton, E Gianatti, BJ Strauss, J Wentworth, D Lim‐Joon, D Bolton, ...
Clinical endocrinology 74 (3), 377-383, 2011
|Urinary stone disease|
Smith's Urology, 2000
|The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the LIFT Study|
CG Roehrborn, SN Gange, ND Shore, JL Giddens, DM Bolton, BE Cowan, ...
The Journal of urology 190 (6), 2161-2167, 2013
|Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories|
RA Taylor, M Fraser, J Livingstone, SMG Espiritu, H Thorne, V Huang, ...
Nature communications 8 (1), 1-10, 2017
|Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia|
PT Chin, DM Bolton, G Jack, P Rashid, J Thavaseelan, RJ Yu, ...
Urology 79 (1), 5-11, 2012
|Assessing regional hypoxia in human renal tumours using 18F‐fluoromisonidazole positron emission tomography|
N Lawrentschuk, AMT Poon, SS Foo, LGJ Putra, C Murone, ID Davis, ...
BJU international 96 (4), 540-546, 2005
|Five year results of the prospective randomized controlled prostatic urethral LIFT study|
C Roehrborn, J Barkin, SN Gange, ND Shore, JL Giddens, DM Bolton, ...
Canadian Journal of Urology 24 (3), 8802-8813, 2017
|Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review|
N Lawrentschuk, J Gani, R Riordan, S Esler, DM Bolton
BJU international 96 (3), 291-295, 2005
|Mobile phone interference with medical equipment and its clinical relevance: a systematic review|
N Lawrentschuk, DM Bolton
Medical journal of Australia 181 (3), 145-149, 2004
|The CROES percutaneous nephrolithotomy global study: the influence of body mass index on outcome|
A Fuller, H Razvi, JD Denstedt, L Nott, M Pearle, F Cauda, D Bolton, ...
The Journal of urology 188 (1), 138-144, 2012
|Current indications for open stone surgery in an endourology center|
CJ Kane, DM Bolton, ML Stoller
Urology 45 (2), 218-221, 1995
|Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families|
H Thorne, AJ Willems, E Niedermayr, IMY Hoh, J Li, D Clouston, ...
Cancer Prevention Research 4 (7), 1002-1010, 2011
|Minimally invasive prostatic urethral lift: surgical technique and multinational experience|
TA McNicholas, HH Woo, PT Chin, D Bolton, MF Arjona, KD Sievert, ...
European urology 64 (2), 292-299, 2013
|Improved renal function following aggressive treatment of urolithiasis and concurrent mild to moderate renal insufficiency|
M Gupta, DM Bolton, PN Gupta, ML Stoller
The Journal of urology 152 (4), 1086-1090, 1994
|The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma|
S Hinz, M Schrader, C Kempkensteffen, R Bares, W Brenner, S Krege, ...
The Journal of urology 179 (3), 936-940, 2008